INTERNATIONAL PATENT: SCINNOHUB PHARMACEUTICAL CO., LTD, 赛诺哈勃药业（成都）有限公司 FILES APPLICATION FOR "HETEROCYCLIC COMPOUND AND USE THEREOF AS RET INHIBITOR"

GENEVA, Oct. 26 -- SCINNOHUB PHARMACEUTICAL CO., LTD (No. 15, Gaopeng Avenue, High-Tech Development ZoneChengdu, Sichuan 610041), 赛诺哈勃药业（成都）有限公司 (中国四川省成都市高新区高朋大道15号) filed a patent application (PCT/CN2025/089785) for "HETEROCYCLIC COMPOUND AND USE THEREOF AS RET INHIBITOR" on Apr 18, 2025. With publication no. WO/2025/218778, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the Worl...